TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma
暂无分享,去创建一个
J. Yonese | N. Matsubara | S. Fukasawa | H. Miyake | Masatoshi Eto | Takashi Kawahara | S. Suekane | Hiroyuki Nishiyama | Hiroji Uemura | Haruhito Azuma | Wataru Obara | Akito Terai | Ryuji Matsumoto